US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Lipocine

7.15

-0.2500-3.38%

Post-market: 7.150.00000.00%16:25 EDT

Volume:65.02K

Turnover:467.05K

Market Cap:52.19M

PE:-4.05

High:7.66

Open:7.40

Low:6.89

Close:7.40

52wk High:12.37

52wk Low:2.52

Shares:7.30M

Float Shares:6.61M

Volume Ratio:0.77

T/O Rate:0.98%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.7669

EPS(LYR):-1.7669

ROE:-54.28%

ROA:-32.81%

PB:3.61

PE(LYR):-4.05

Loading ...

Overview Company News Filings

Lipocine price target raised to $11 from $6.75 at Alliance Global

Press Release: Lipocine Announces Financial Results for the Full Year Ended December 31, 2025

Lipocine FY2025 revenue fell 82% to USD 1.98 million as net loss totaled USD 9.6 million

Lipocine Inc expected to post a loss of 61 cents a share - Earnings Preview

Lipocine Files Prospectus to Enable $50M Stock Offering

BRIEF-Lipocine Files For Common Stock Offering Of Up To $50 Million - SEC Filing

Lipocine Updates Investor Presentation to Reflect Latest Strategy

Lipocine Reports Last Patient Last Visit in Phase 3 Trial of LPCN 1154 for Postpartum Depression

Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of Lpcn 1154 for Postpartum Depression (Ppd)

THOMSON REUTERS

Lipocine Is Maintained at Buy by HC Wainwright & Co.

Lipocine price target raised to $15 from $7 at H.C. Wainwright

Lipocine Completes Phase 3 Enrollment for Postpartum Depression Drug

BRIEF-Lipocine Announces Completion Of Enrollment And Dosing In Phase 3 Trial Of LPCN 1154 In Postpartum Depression

Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of Lpcn 1154 in Postpartum Depression (Ppd)

THOMSON REUTERS

Lipocine Inc - Topline Results Expected Early Q2 2026

THOMSON REUTERS

Lipocine updates investor presentation and corporate materials

Lipocine Advances Phase 3 Postpartum Depression Drug Trial

Lipocine: DSMB recommended Phase 3 LPCN 1154 continue as planned

Lipocine Completes Phase 3 Safety Review of LPCN 1154 for Postpartum Depression

Lipocine Reports Encouraging Progress Post Second Interim Safety Review in Phase 3 Trial of Lpcn 1154 in Postpartum Depression (Ppd)

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LPCN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LPCN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LPCN\",,,,,undefined,":{"symbol":"LPCN","market":"US","secType":"STK","nameCN":"Lipocine","latestPrice":7.15,"timestamp":1774641600000,"preClose":7.4,"halted":0,"volume":65024,"hourTrading":{"tag":"盘后","latestPrice":7.15,"preClose":7.15,"latestTime":"16:25 EDT","volume":14,"amount":99.68,"timestamp":1774643105994,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.03378378378378378,"floatShares":6611900,"shares":7299687,"eps":-1.76688,"marketStatus":"Market Closed","change":-0.25,"latestTime":"03-27 16:00:00 EDT","open":7.4,"high":7.655,"low":6.89,"amount":467045.7994,"amplitude":0.103378,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.76688,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1395374400000,"exchange":"NASDAQ","adjPreClose":7.4,"postHourTrading":{"tag":"盘后","latestPrice":7.15,"preClose":7.15,"latestTime":"16:25 EDT","volume":14,"amount":99.68,"timestamp":1774643105994,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.767984,"impliedVol":2.2886,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LPCN\",,,,,undefined,":{"symbol":"LPCN","floatShares":6611900,"roa":"-32.81%","roe":"-54.28%","lyrEps":-1.76688,"volumeRatio":0.767984,"shares":7299687,"dividePrice":0,"high":7.655,"amplitude":0.103378,"preClose":7.4,"low":6.89,"week52Low":2.52,"pbRate":"3.61","psRate":"26.40","week52High":12.37,"institutionHeld":0,"latestPrice":7.15,"eps":-1.76688,"divideRate":0,"volume":65024,"delay":0,"ttmEps":-1.76688,"open":7.4,"prevYearClose":8.03,"prevWeekClose":7.15,"prevMonthClose":9.96,"prevQuarterClose":8.03,"fiveDayClose":7.15,"twentyDayClose":9.96,"sixtyDayClose":6.57},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LPCN\",params:#limit:5,,,undefined,":[{"date":"2026-03-10","symbol":"LPCN","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1773129600000,"name":null,"time":"Pre-Market","dateTimestamp":1773115200000,"actualEps":null},{"market":"US","date":"2025-11-06","symbol":"LPCN","fiscalQuarterEnding":"2025/09","expectedEps":-0.56,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.59},{"market":"US","date":"2025-08-05","symbol":"LPCN","fiscalQuarterEnding":"2025/06","expectedEps":-0.41,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-0.41},{"market":"US","date":"2025-05-08","symbol":"LPCN","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2025-03-13","symbol":"LPCN","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741838400000,"reportTimeType":"pre","actualEps":0.33}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LPCN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LPCN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1748577600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LPCN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LPCN","date":"2026-03-27","current":-4.046681,"percent":0.288693,"low":-257.46841,"twenty":-6.278531,"median":-3.362565,"eighty":-1.222938,"high":2357.436542,"avg":52.721866,"sd":367.437504,"marketCap":54017683},"quantilePoints":[{"date":"2021-04-01","current":-6.527626,"twenty":-4.894079,"median":-3.563783,"eighty":-1.805681,"marketCap":136850507},{"date":"2021-04-09","current":-6.485513,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":135967601},{"date":"2021-04-16","current":-6.148603,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":128904349},{"date":"2021-04-23","current":-6.190717,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":129787255},{"date":"2021-04-30","current":-5.938034,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":124489816},{"date":"2021-05-07","current":-6.611483,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":122724003},{"date":"2021-05-14","current":-6.183402,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":114777845},{"date":"2021-05-21","current":-6.896871,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":128021442},{"date":"2021-05-28","current":-5.802885,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":107714593},{"date":"2021-06-04","current":-5.850449,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":108597499},{"date":"2021-06-11","current":-6.326095,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":117426564},{"date":"2021-06-18","current":-6.468789,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":120075284},{"date":"2021-06-25","current":-7.134694,"twenty":-4.894079,"median":-3.559099,"eighty":-1.803404,"marketCap":132435975},{"date":"2021-07-02","current":-6.992,"twenty":-4.923396,"median":-3.569952,"eighty":-1.803404,"marketCap":129787255},{"date":"2021-07-09","current":-6.468789,"twenty":-4.964892,"median":-3.575128,"eighty":-1.803404,"marketCap":120075284},{"date":"2021-07-16","current":-5.993143,"twenty":-4.996255,"median":-3.584073,"eighty":-1.803404,"marketCap":111246219},{"date":"2021-07-23","current":-6.278531,"twenty":-5.036066,"median":-3.593536,"eighty":-1.803404,"marketCap":116543658},{"date":"2021-07-30","current":-6.278531,"twenty":-5.082397,"median":-3.593536,"eighty":-1.803404,"marketCap":116543658},{"date":"2021-08-06","current":-6.319201,"twenty":-5.114441,"median":-3.594594,"eighty":-1.803404,"marketCap":120075284},{"date":"2021-08-13","current":-6.737383,"twenty":-5.134595,"median":-3.594594,"eighty":-1.803404,"marketCap":128021442},{"date":"2021-08-20","current":-6.458595,"twenty":-5.249763,"median":-3.594594,"eighty":-1.803404,"marketCap":122724003},{"date":"2021-08-27","current":-6.179807,"twenty":-5.289324,"median":-3.594594,"eighty":-1.803404,"marketCap":117426564},{"date":"2021-09-03","current":-5.808089,"twenty":-5.334785,"median":-3.594594,"eighty":-1.803404,"marketCap":110363312},{"date":"2021-09-10","current":-5.62223,"twenty":-5.383758,"median":-3.594594,"eighty":-1.803404,"marketCap":106831686},{"date":"2021-09-17","current":-5.389906,"twenty":-5.39031,"median":-3.594594,"eighty":-1.803404,"marketCap":102417154},{"date":"2021-09-24","current":-5.111118,"twenty":-5.39031,"median":-3.594594,"eighty":-1.803404,"marketCap":97119715},{"date":"2021-10-01","current":-4.925259,"twenty":-5.39031,"median":-3.594594,"eighty":-1.803404,"marketCap":93588089},{"date":"2021-10-08","current":-4.878795,"twenty":-5.383758,"median":-3.594594,"eighty":-1.803404,"marketCap":92705182},{"date":"2021-10-15","current":-5.250512,"twenty":-5.340243,"median":-3.594594,"eighty":-1.803404,"marketCap":99768434},{"date":"2021-10-22","current":-4.925259,"twenty":-5.350723,"median":-3.594594,"eighty":-1.803404,"marketCap":93588089},{"date":"2021-10-29","current":-4.83233,"twenty":-5.348296,"median":-3.594594,"eighty":-1.805681,"marketCap":91822276},{"date":"2021-11-05","current":-5.204048,"twenty":-5.363631,"median":-3.594594,"eighty":-1.805681,"marketCap":98885528},{"date":"2021-11-12","current":-5.912643,"twenty":-5.415979,"median":-3.594594,"eighty":-1.805681,"marketCap":105065873},{"date":"2021-11-19","current":-5.813271,"twenty":-5.423851,"median":-3.594594,"eighty":-1.805681,"marketCap":103300060},{"date":"2021-11-26","current":-5.614527,"twenty":-5.478962,"median":-3.595816,"eighty":-1.805681,"marketCap":99768434},{"date":"2021-12-03","current":-5.018294,"twenty":-5.478962,"median":-3.601693,"eighty":-1.805681,"marketCap":89173556},{"date":"2021-12-10","current":-5.564841,"twenty":-5.491958,"median":-3.601693,"eighty":-1.805681,"marketCap":98885528},{"date":"2021-12-17","current":-5.415782,"twenty":-5.491958,"median":-3.606179,"eighty":-1.805681,"marketCap":96236808},{"date":"2021-12-23","current":-5.266724,"twenty":-5.491958,"median":-3.606179,"eighty":-1.805681,"marketCap":93588089},{"date":"2021-12-31","current":-4.924387,"twenty":-5.491958,"median":-3.606179,"eighty":-1.805681,"marketCap":87504863},{"date":"2022-01-07","current":-5.117666,"twenty":-5.49044,"median":-3.607985,"eighty":-1.807958,"marketCap":90939369},{"date":"2022-01-14","current":-4.946746,"twenty":-5.49044,"median":-3.62027,"eighty":-1.807958,"marketCap":87902171},{"date":"2022-01-21","current":-4.427526,"twenty":-5.49044,"median":-3.63139,"eighty":-1.807958,"marketCap":78675798},{"date":"2022-01-28","current":-4.828493,"twenty":-5.49044,"median":-3.649414,"eighty":-1.807958,"marketCap":85800853},{"date":"2022-02-04","current":-4.774832,"twenty":-5.49044,"median":-3.649414,"eighty":-1.807958,"marketCap":84847314},{"date":"2022-02-11","current":-5.31641,"twenty":-5.49044,"median":-3.649414,"eighty":-1.807958,"marketCap":94470995},{"date":"2022-02-18","current":-6.21076,"twenty":-5.515155,"median":-3.649414,"eighty":-1.807958,"marketCap":110363312},{"date":"2022-02-25","current":-6.061702,"twenty":-5.529301,"median":-3.649414,"eighty":-1.807958,"marketCap":107714593},{"date":"2022-03-04","current":-7.452912,"twenty":-5.556915,"median":-3.649414,"eighty":-1.807958,"marketCap":132435975},{"date":"2022-03-11","current":-212.933334,"twenty":-5.576022,"median":-3.649414,"eighty":-1.807958,"marketCap":135084694},{"date":"2022-03-18","current":-221.283661,"twenty":-5.600651,"median":-3.649414,"eighty":-1.807958,"marketCap":140382133},{"date":"2022-03-25","current":-257.46841,"twenty":-5.625274,"median":-3.649414,"eighty":-1.807958,"marketCap":163337702},{"date":"2022-04-01","current":-186.490633,"twenty":-5.665109,"median":-3.649414,"eighty":-1.807958,"marketCap":118309471},{"date":"2022-04-08","current":-164.223095,"twenty":-5.717985,"median":-3.649414,"eighty":-1.807958,"marketCap":104182967},{"date":"2022-04-14","current":-147.87044,"twenty":-5.755906,"median":-3.649414,"eighty":-1.807958,"marketCap":93808859},{"date":"2022-04-22","current":-137.714809,"twenty":-5.802885,"median":-3.649414,"eighty":-1.807958,"marketCap":87366137},{"date":"2022-04-29","current":-123.025416,"twenty":-5.811693,"median":-3.649414,"eighty":-1.807958,"marketCap":78047201},{"date":"2022-05-06","current":-113.037186,"twenty":-5.813271,"median":-3.649414,"eighty":-1.807958,"marketCap":71710678},{"date":"2022-05-13","current":-91.186847,"twenty":-5.841119,"median":-3.666486,"eighty":-1.807958,"marketCap":68763819},{"date":"2022-05-20","current":-106.06779,"twenty":-5.853956,"median":-3.691692,"eighty":-1.807958,"marketCap":79985508},{"date":"2022-05-27","current":-100.939263,"twenty":-5.866177,"median":-3.728107,"eighty":-1.807958,"marketCap":76118096},{"date":"2022-06-03","current":-97.81755,"twenty":-5.912643,"median":-3.73964,"eighty":-1.807958,"marketCap":73764019},{"date":"2022-06-10","current":-102.101102,"twenty":-5.945578,"median":-3.768833,"eighty":-1.807958,"marketCap":76994237},{"date":"2022-06-17","current":-94.883611,"twenty":-5.993143,"median":-3.794864,"eighty":-1.807958,"marketCap":71551541},{"date":"2022-06-24","current":-96.397524,"twenty":-6.022262,"median":-3.824312,"eighty":-1.805681,"marketCap":72693180},{"date":"2022-07-01","current":-93.886072,"twenty":-6.04053,"median":-3.832964,"eighty":-1.805681,"marketCap":70799299},{"date":"2022-07-08","current":-91.844049,"twenty":-6.061702,"median":-3.850115,"eighty":-1.805681,"marketCap":69259414},{"date":"2022-07-15","current":-92.747703,"twenty":-6.100131,"median":-3.86568,"eighty":-1.805681,"marketCap":69940857},{"date":"2022-07-22","current":-91.538919,"twenty":-6.131645,"median":-3.86568,"eighty":-1.805681,"marketCap":69029316},{"date":"2022-07-29","current":-88.428943,"twenty":-6.160986,"median":-3.86568,"eighty":-1.805681,"marketCap":66684089},{"date":"2022-08-05","current":-96.573561,"twenty":-6.186328,"median":-3.87803,"eighty":-1.805681,"marketCap":72825929},{"date":"2022-08-12","current":18.241699,"twenty":-6.186328,"median":-3.86568,"eighty":-1.790828,"marketCap":62444363},{"date":"2022-08-19","current":15.767266,"twenty":-6.186328,"median":-3.86568,"eighty":-1.774903,"marketCap":53973968},{"date":"2022-08-26","current":15.113073,"twenty":-6.186328,"median":-3.86568,"eighty":-1.744599,"marketCap":51734557},{"date":"2022-09-02","current":14.735569,"twenty":-6.186328,"median":-3.86568,"eighty":-1.740239,"marketCap":50442299},{"date":"2022-09-09","current":13.310881,"twenty":-6.186328,"median":-3.86568,"eighty":-1.727982,"marketCap":45565355},{"date":"2022-09-16","current":14.660586,"twenty":-6.186328,"median":-3.86568,"eighty":-1.725301,"marketCap":50185618},{"date":"2022-09-23","current":12.837708,"twenty":-6.186328,"median":-3.86568,"eighty":-1.701339,"marketCap":43945607},{"date":"2022-09-30","current":11.635385,"twenty":-6.186328,"median":-3.86568,"eighty":-1.673028,"marketCap":39829855},{"date":"2022-10-07","current":11.764667,"twenty":-6.186328,"median":-3.86568,"eighty":-1.657962,"marketCap":40272409},{"date":"2022-10-14","current":11.635385,"twenty":-6.186328,"median":-3.86568,"eighty":-1.637693,"marketCap":39829855},{"date":"2022-10-21","current":11.410435,"twenty":-6.186328,"median":-3.86568,"eighty":-1.621479,"marketCap":39059812},{"date":"2022-10-28","current":10.66577,"twenty":-6.186328,"median":-3.86568,"eighty":-1.607909,"marketCap":36510701},{"date":"2022-11-04","current":10.233968,"twenty":-6.186328,"median":-3.86568,"eighty":-1.591322,"marketCap":35032571},{"date":"2022-11-11","current":8.245255,"twenty":-6.186328,"median":-3.859558,"eighty":-1.586401,"marketCap":33766778},{"date":"2022-11-18","current":10.376297,"twenty":-6.186328,"median":-3.856954,"eighty":-1.573457,"marketCap":42494030},{"date":"2022-11-25","current":10.300653,"twenty":-6.186328,"median":-3.856954,"eighty":-1.569985,"marketCap":42184242},{"date":"2022-12-02","current":9.730075,"twenty":-6.186328,"median":-3.856954,"eighty":-1.56875,"marketCap":39847558},{"date":"2022-12-09","current":8.759661,"twenty":-6.186328,"median":-3.856954,"eighty":-1.560663,"marketCap":35873423},{"date":"2022-12-16","current":9.185433,"twenty":-6.186328,"median":-3.856954,"eighty":-1.557464,"marketCap":37617086},{"date":"2022-12-23","current":8.768306,"twenty":-6.186328,"median":-3.856954,"eighty":-1.548676,"marketCap":35908827},{"date":"2022-12-30","current":8.597565,"twenty":-6.186328,"median":-3.856954,"eighty":-1.545785,"marketCap":35209592},{"date":"2023-01-06","current":10.371975,"twenty":-6.186328,"median":-3.850115,"eighty":-1.533246,"marketCap":42476328},{"date":"2023-01-13","current":12.02103,"twenty":-6.186328,"median":-3.829635,"eighty":-1.525522,"marketCap":49229701},{"date":"2023-01-20","current":11.670903,"twenty":-6.186328,"median":-3.829635,"eighty":-1.520136,"marketCap":47795827},{"date":"2023-01-27","current":11.554194,"twenty":-6.186328,"median":-3.829635,"eighty":-1.513461,"marketCap":47317868},{"date":"2023-02-03","current":11.887031,"twenty":-6.186328,"median":-3.829635,"eighty":-1.504455,"marketCap":48680935},{"date":"2023-02-10","current":11.433163,"twenty":-6.186328,"median":-3.829635,"eighty":-1.504455,"marketCap":46822208},{"date":"2023-02-17","current":10.806392,"twenty":-6.186328,"median":-3.829635,"eighty":-1.501034,"marketCap":44255395},{"date":"2023-02-24","current":9.302142,"twenty":-6.186328,"median":-3.829635,"eighty":-1.501034,"marketCap":38095044},{"date":"2023-03-03","current":9.496657,"twenty":-6.186328,"median":-3.829635,"eighty":-1.499868,"marketCap":38891641},{"date":"2023-03-10","current":-2.529788,"twenty":-6.186328,"median":-3.829635,"eighty":-1.489742,"marketCap":27217068},{"date":"2023-03-17","current":-2.859689,"twenty":-6.186328,"median":-3.829635,"eighty":-1.492333,"marketCap":30766350},{"date":"2023-03-24","current":-2.446696,"twenty":-6.186328,"median":-3.829635,"eighty":-1.492333,"marketCap":26323109},{"date":"2023-03-31","current":-2.616994,"twenty":-6.184865,"median":-3.827523,"eighty":-1.498706,"marketCap":28155282},{"date":"2023-04-06","current":-2.631802,"twenty":-6.184865,"median":-3.827523,"eighty":-1.498706,"marketCap":28314602},{"date":"2023-04-14","current":-2.459859,"twenty":-6.186328,"median":-3.829635,"eighty":-1.497544,"marketCap":26464726},{"date":"2023-04-21","current":-2.476313,"twenty":-6.186328,"median":-3.829635,"eighty":-1.497544,"marketCap":26641748},{"date":"2023-04-28","current":-2.303547,"twenty":-6.186328,"median":-3.829635,"eighty":-1.497544,"marketCap":24783021},{"date":"2023-05-05","current":-2.053447,"twenty":-6.186328,"median":-3.829635,"eighty":-1.497566,"marketCap":22092293},{"date":"2023-05-12","current":-2.264193,"twenty":-6.186328,"median":-3.829635,"eighty":-1.501087,"marketCap":25225570},{"date":"2023-05-19","current":-1.715085,"twenty":-6.186328,"median":-3.829635,"eighty":-1.525522,"marketCap":19107906},{"date":"2023-05-26","current":-2.434766,"twenty":-6.187791,"median":-3.832756,"eighty":-1.542663,"marketCap":27125937},{"date":"2023-06-02","current":-2.014173,"twenty":-6.187791,"median":-3.832756,"eighty":-1.550008,"marketCap":22440075},{"date":"2023-06-09","current":-2.070252,"twenty":-6.187791,"median":-3.832756,"eighty":-1.557464,"marketCap":23064857},{"date":"2023-06-16","current":-2.350648,"twenty":-6.187791,"median":-3.832756,"eighty":-1.563166,"marketCap":26188765},{"date":"2023-06-23","current":-2.327281,"twenty":-6.189254,"median":-3.835877,"eighty":-1.569999,"marketCap":25928439},{"date":"2023-06-30","current":-2.285222,"twenty":-6.190717,"median":-3.841919,"eighty":-1.589344,"marketCap":25459853},{"date":"2023-07-07","current":-2.010014,"twenty":-6.190717,"median":-3.841919,"eighty":-1.591322,"marketCap":22393737},{"date":"2023-07-14","current":-2.088945,"twenty":-6.190717,"median":-3.841919,"eighty":-1.6107,"marketCap":23273117},{"date":"2023-07-21","current":-2.004827,"twenty":-6.190717,"median":-3.841919,"eighty":-1.668335,"marketCap":22335945},{"date":"2023-07-28","current":-2.38336,"twenty":-6.190717,"median":-3.847962,"eighty":-1.713183,"marketCap":26553221},{"date":"2023-08-04","current":-2.294569,"twenty":-6.190717,"median":-3.847962,"eighty":-1.727826,"marketCap":25563983},{"date":"2023-08-11","current":-2.163275,"twenty":-6.190717,"median":-3.847962,"eighty":-1.7378,"marketCap":26084635},{"date":"2023-08-18","current":-1.997084,"twenty":-6.190717,"median":-3.847962,"eighty":-1.7378,"marketCap":24080709},{"date":"2023-08-25","current":-1.816332,"twenty":-6.190717,"median":-3.847962,"eighty":-1.7378,"marketCap":21901219},{"date":"2023-09-01","current":-1.741386,"twenty":-6.190717,"median":-3.847962,"eighty":-1.7378,"marketCap":20997528},{"date":"2023-09-08","current":-1.609129,"twenty":-6.190717,"median":-3.847962,"eighty":-1.726955,"marketCap":19402779},{"date":"2023-09-15","current":-1.670849,"twenty":-6.190717,"median":-3.847962,"eighty":-1.697959,"marketCap":20146995},{"date":"2023-09-22","current":-1.450421,"twenty":-6.190717,"median":-3.847962,"eighty":-1.673339,"marketCap":17489080},{"date":"2023-09-29","current":-1.247626,"twenty":-6.190717,"median":-3.847962,"eighty":-1.652504,"marketCap":15043798},{"date":"2023-10-06","current":-1.225583,"twenty":-6.190717,"median":-3.847962,"eighty":-1.608783,"marketCap":14778007},{"date":"2023-10-13","current":-1.221175,"twenty":-6.190717,"median":-3.847962,"eighty":-1.578112,"marketCap":14724849},{"date":"2023-10-20","current":-1.14182,"twenty":-6.190717,"median":-3.847962,"eighty":-1.544351,"marketCap":13767999},{"date":"2023-10-27","current":-1.084509,"twenty":-6.190717,"median":-3.850115,"eighty":-1.533661,"marketCap":13076941},{"date":"2023-11-03","current":-1.137412,"twenty":-6.190717,"median":-3.850115,"eighty":-1.497674,"marketCap":13714841},{"date":"2023-11-10","current":-0.772927,"twenty":-6.190717,"median":-3.850115,"eighty":-1.452788,"marketCap":12598517},{"date":"2023-11-17","current":-0.88055,"twenty":-6.190717,"median":-3.850115,"eighty":-1.374405,"marketCap":14352741},{"date":"2023-11-24","current":-0.815324,"twenty":-6.190717,"median":-3.850115,"eighty":-1.314476,"marketCap":13289575},{"date":"2023-12-01","current":-0.785973,"twenty":-6.190717,"median":-3.850115,"eighty":-1.302121,"marketCap":12811150},{"date":"2023-12-08","current":-0.849013,"twenty":-6.190717,"median":-3.850115,"eighty":-1.287218,"marketCap":13838700},{"date":"2023-12-15","current":-0.834892,"twenty":-6.190717,"median":-3.850115,"eighty":-1.266818,"marketCap":13608524},{"date":"2023-12-22","current":-0.954027,"twenty":-6.190717,"median":-3.850115,"eighty":-1.247626,"marketCap":15550397},{"date":"2023-12-29","current":-0.926208,"twenty":-6.190717,"median":-3.850115,"eighty":-1.24649,"marketCap":15096957},{"date":"2024-01-05","current":-0.968605,"twenty":-6.190717,"median":-3.850115,"eighty":-1.243218,"marketCap":15788015},{"date":"2024-01-12","current":-1.014263,"twenty":-6.190717,"median":-3.850115,"eighty":-1.229992,"marketCap":16532231},{"date":"2024-01-19","current":-1.30778,"twenty":-6.190717,"median":-3.853535,"eighty":-1.22911,"marketCap":21316478},{"date":"2024-01-26","current":-1.249077,"twenty":-6.190717,"median":-3.850115,"eighty":-1.225583,"marketCap":20359628},{"date":"2024-02-02","current":-1.297996,"twenty":-6.190717,"median":-3.850115,"eighty":-1.225583,"marketCap":21157003},{"date":"2024-02-09","current":-1.30778,"twenty":-6.190717,"median":-3.850115,"eighty":-1.225583,"marketCap":21316478},{"date":"2024-02-16","current":-1.30778,"twenty":-6.190717,"median":-3.850115,"eighty":-1.225583,"marketCap":21316478},{"date":"2024-02-23","current":-1.271906,"twenty":-6.190717,"median":-3.850115,"eighty":-1.225583,"marketCap":20731737},{"date":"2024-03-01","current":-1.242554,"twenty":-6.190717,"median":-3.850115,"eighty":-1.226368,"marketCap":20253312},{"date":"2024-03-08","current":-1.180061,"twenty":-6.190717,"median":-3.841919,"eighty":-1.22267,"marketCap":19296462},{"date":"2024-03-15","current":-1.524652,"twenty":-6.190717,"median":-3.820107,"eighty":-1.219441,"marketCap":24931242},{"date":"2024-03-22","current":-1.336103,"twenty":-6.190717,"median":-3.777296,"eighty":-1.219441,"marketCap":21848061},{"date":"2024-03-28","current":-1.6673,"twenty":-6.190717,"median":-3.515893,"eighty":-1.219441,"marketCap":27263828},{"date":"2024-04-05","current":-1.498646,"twenty":-6.190717,"median":-3.447774,"eighty":-1.219007,"marketCap":24505976},{"date":"2024-04-12","current":-2.0838,"twenty":-6.190717,"median":-3.399569,"eighty":-1.219007,"marketCap":34074470},{"date":"2024-04-19","current":-1.768467,"twenty":-6.190717,"median":-3.352097,"eighty":-1.219007,"marketCap":28918115},{"date":"2024-04-26","current":-1.47914,"twenty":-6.190717,"median":-3.325493,"eighty":-1.219441,"marketCap":24187026},{"date":"2024-05-03","current":-1.537133,"twenty":-6.190717,"median":-3.296372,"eighty":-1.219441,"marketCap":25135318},{"date":"2024-05-10","current":-3.124719,"twenty":-6.190717,"median":-3.245681,"eighty":-1.219441,"marketCap":28023205},{"date":"2024-05-17","current":-3.428843,"twenty":-6.190717,"median":-3.236813,"eighty":-1.219441,"marketCap":30750655},{"date":"2024-05-24","current":-3.899936,"twenty":-6.190717,"median":-3.281153,"eighty":-1.219441,"marketCap":34975527},{"date":"2024-05-31","current":-4.126538,"twenty":-6.190717,"median":-3.333973,"eighty":-1.219441,"marketCap":37007744},{"date":"2024-06-07","current":-4.48433,"twenty":-6.190717,"median":-3.352097,"eighty":-1.219441,"marketCap":40216508},{"date":"2024-06-14","current":-5.659081,"twenty":-6.190717,"median":-3.423041,"eighty":-1.219441,"marketCap":50751950},{"date":"2024-06-21","current":-5.354958,"twenty":-6.190717,"median":-3.458513,"eighty":-1.219007,"marketCap":48024501},{"date":"2024-06-28","current":-4.913681,"twenty":-6.190717,"median":-3.601693,"eighty":-1.219007,"marketCap":44067025},{"date":"2024-07-05","current":-4.347176,"twenty":-6.190717,"median":-3.798562,"eighty":-1.219007,"marketCap":38986482},{"date":"2024-07-12","current":-4.585705,"twenty":-6.190717,"median":-3.86568,"eighty":-1.219007,"marketCap":41125658},{"date":"2024-07-19","current":-3.369211,"twenty":-6.190717,"median":-3.899936,"eighty":-1.219007,"marketCap":30215861},{"date":"2024-07-26","current":-3.285726,"twenty":-6.190717,"median":-3.899936,"eighty":-1.219007,"marketCap":29467149},{"date":"2024-08-02","current":-2.95775,"twenty":-6.190717,"median":-3.899936,"eighty":-1.219007,"marketCap":26525782},{"date":"2024-08-09","current":-2.778482,"twenty":-6.190717,"median":-3.899936,"eighty":-1.219007,"marketCap":23584415},{"date":"2024-08-16","current":-2.331153,"twenty":-6.190717,"median":-3.822414,"eighty":-1.219007,"marketCap":19787378},{"date":"2024-08-23","current":-2.312252,"twenty":-6.190717,"median":-3.774709,"eighty":-1.219007,"marketCap":19626939},{"date":"2024-08-30","current":-2.312252,"twenty":-6.190717,"median":-3.509342,"eighty":-1.219007,"marketCap":19626939},{"date":"2024-09-06","current":-2.305951,"twenty":-6.183402,"median":-3.428843,"eighty":-1.219007,"marketCap":19573460},{"date":"2024-09-13","current":-2.904491,"twenty":-6.179807,"median":-3.285726,"eighty":-1.219007,"marketCap":24654003},{"date":"2024-09-20","current":-3.0494,"twenty":-6.179807,"median":-3.135292,"eighty":-1.219007,"marketCap":25884029},{"date":"2024-09-27","current":-2.797384,"twenty":-6.179807,"median":-3.0494,"eighty":-1.219007,"marketCap":23744853},{"date":"2024-10-04","current":-2.935993,"twenty":-6.179807,"median":-3.005455,"eighty":-1.219007,"marketCap":24921400},{"date":"2024-10-11","current":-3.238413,"twenty":-6.179807,"median":-3.005455,"eighty":-1.219007,"marketCap":27488411},{"date":"2024-10-18","current":-3.295116,"twenty":-6.160927,"median":-3.005455,"eighty":-1.219007,"marketCap":27969726},{"date":"2024-10-25","current":-3.635339,"twenty":-6.135837,"median":-3.005455,"eighty":-1.219007,"marketCap":30857613},{"date":"2024-11-01","current":-3.830652,"twenty":-6.135837,"median":-3.005455,"eighty":-1.219007,"marketCap":32515475},{"date":"2024-11-08","current":-6.276052,"twenty":-6.161074,"median":-3.005455,"eighty":-1.219007,"marketCap":25456194},{"date":"2024-11-15","current":-6.447457,"twenty":-6.190717,"median":-3.047586,"eighty":-1.221175,"marketCap":26151426},{"date":"2024-11-22","current":-6.790266,"twenty":-6.210127,"median":-3.124719,"eighty":-1.225583,"marketCap":27541891},{"date":"2024-11-29","current":-5.985982,"twenty":-6.21076,"median":-3.156507,"eighty":-1.230089,"marketCap":24279647},{"date":"2024-12-06","current":-6.724342,"twenty":-6.230966,"median":-3.20061,"eighty":-1.243218,"marketCap":27274494},{"date":"2024-12-13","current":-6.618861,"twenty":-6.272736,"median":-3.285726,"eighty":-1.246712,"marketCap":26846658},{"date":"2024-12-20","current":-6.421087,"twenty":-6.276052,"median":-3.351321,"eighty":-1.249077,"marketCap":26044467},{"date":"2024-12-27","current":-6.276052,"twenty":-6.278531,"median":-3.447774,"eighty":-1.258071,"marketCap":25456194},{"date":"2025-01-03","current":-6.671601,"twenty":-6.278531,"median":-3.470585,"eighty":-1.260287,"marketCap":27060576},{"date":"2025-01-10","current":-6.447457,"twenty":-6.32058,"median":-3.509336,"eighty":-1.269051,"marketCap":26151426},{"date":"2025-01-17","current":-5.761838,"twenty":-6.32058,"median":-3.602806,"eighty":-1.276131,"marketCap":23370497},{"date":"2025-01-24","current":-6.183757,"twenty":-6.32058,"median":-3.780552,"eighty":-1.276131,"marketCap":25081838},{"date":"2025-01-31","current":-5.695913,"twenty":-6.32058,"median":-3.820233,"eighty":-1.28169,"marketCap":23103100},{"date":"2025-02-07","current":-4.614744,"twenty":-6.32058,"median":-3.889341,"eighty":-1.286942,"marketCap":18717790},{"date":"2025-02-14","current":-4.786149,"twenty":-6.32058,"median":-3.962351,"eighty":-1.297621,"marketCap":19413022},{"date":"2025-02-21","current":-4.456524,"twenty":-6.32058,"median":-4.104421,"eighty":-1.297996,"marketCap":18076037},{"date":"2025-02-28","current":-4.04779,"twenty":-6.32058,"median":-4.125777,"eighty":-1.303214,"marketCap":16418175},{"date":"2025-03-07","current":-4.535634,"twenty":-6.321959,"median":-4.15327,"eighty":-1.30191,"marketCap":18396913},{"date":"2025-03-14","current":2146.03592,"twenty":-6.321959,"median":-4.155799,"eighty":-1.297246,"marketCap":17923692},{"date":"2025-03-21","current":2267.751437,"twenty":-6.321959,"median":-4.155799,"eighty":-1.292126,"marketCap":18940260},{"date":"2025-03-28","current":2101.193367,"twenty":-6.321959,"median":-4.155799,"eighty":-1.283647,"marketCap":17549167},{"date":"2025-04-04","current":1928.229286,"twenty":-6.321959,"median":-4.155799,"eighty":-1.270601,"marketCap":16104571},{"date":"2025-04-11","current":1966.665709,"twenty":-6.32058,"median":-4.155799,"eighty":-1.258861,"marketCap":16425592},{"date":"2025-04-17","current":1921.823276,"twenty":-6.32058,"median":-4.155799,"eighty":-1.254295,"marketCap":16051068},{"date":"2025-04-25","current":2043.538673,"twenty":-6.321959,"median":-4.155799,"eighty":-1.243218,"marketCap":17067635},{"date":"2025-05-02","current":2139.629909,"twenty":-6.321959,"median":-4.155799,"eighty":-1.229799,"marketCap":17870189},{"date":"2025-05-09","current":-3.262933,"twenty":-6.321959,"median":-4.155799,"eighty":-1.22382,"marketCap":17522415},{"date":"2025-05-16","current":-3.975299,"twenty":-6.321959,"median":-4.155799,"eighty":-1.22382,"marketCap":21347920},{"date":"2025-05-23","current":-3.676404,"twenty":-6.321959,"median":-4.155799,"eighty":-1.22382,"marketCap":19742813},{"date":"2025-05-30","current":-3.332675,"twenty":-6.321959,"median":-4.155799,"eighty":-1.22382,"marketCap":17896940},{"date":"2025-06-06","current":-3.110497,"twenty":-6.321959,"median":-4.155799,"eighty":-1.22382,"marketCap":16703811},{"date":"2025-06-13","current":-3.148357,"twenty":-6.321959,"median":-4.155799,"eighty":-1.22382,"marketCap":16907124},{"date":"2025-06-20","current":-3.193191,"twenty":-6.323337,"median":-4.161127,"eighty":-1.222938,"marketCap":17147890},{"date":"2025-06-27","current":-3.208136,"twenty":-6.323337,"median":-4.161127,"eighty":-1.222938,"marketCap":17228146},{"date":"2025-07-03","current":-3.088578,"twenty":-6.323337,"median":-4.161127,"eighty":-1.222938,"marketCap":16586103},{"date":"2025-07-11","current":-3.307767,"twenty":-6.323337,"median":-4.142886,"eighty":-1.222938,"marketCap":17763181},{"date":"2025-07-18","current":-3.15832,"twenty":-6.323337,"median":-4.142886,"eighty":-1.222938,"marketCap":16960628},{"date":"2025-07-25","current":-3.307767,"twenty":-6.323337,"median":-4.100978,"eighty":-1.222938,"marketCap":17763181},{"date":"2025-08-01","current":-3.218099,"twenty":-6.323337,"median":-3.961143,"eighty":-1.222938,"marketCap":17281649},{"date":"2025-08-08","current":-3.582862,"twenty":-6.315296,"median":-3.868444,"eighty":-1.222938,"marketCap":16148760},{"date":"2025-08-15","current":-3.655,"twenty":-6.278531,"median":-3.801544,"eighty":-1.222938,"marketCap":16473902},{"date":"2025-08-22","current":-3.618931,"twenty":-6.275609,"median":-3.676404,"eighty":-1.222938,"marketCap":16311331},{"date":"2025-08-29","current":-3.582862,"twenty":-6.274061,"median":-3.655,"eighty":-1.222938,"marketCap":16148760},{"date":"2025-09-05","current":-3.474654,"twenty":-6.274502,"median":-3.630954,"eighty":-1.222057,"marketCap":15661045},{"date":"2025-09-12","current":-3.53477,"twenty":-6.274061,"median":-3.618931,"eighty":-1.222938,"marketCap":15931998},{"date":"2025-09-19","current":-3.37847,"twenty":-6.274061,"median":-3.602806,"eighty":-1.222938,"marketCap":15227522},{"date":"2025-09-26","current":-3.222171,"twenty":-6.274061,"median":-3.570839,"eighty":-1.222938,"marketCap":14523045},{"date":"2025-10-03","current":-3.715115,"twenty":-6.274061,"median":-3.553462,"eighty":-1.222938,"marketCap":16744855},{"date":"2025-10-10","current":-3.787253,"twenty":-6.274061,"median":-3.553462,"eighty":-1.222938,"marketCap":17069998},{"date":"2025-10-17","current":-3.739161,"twenty":-6.274061,"median":-3.553462,"eighty":-1.222938,"marketCap":16853236},{"date":"2025-10-24","current":-3.354424,"twenty":-6.274061,"median":-3.528758,"eighty":-1.222938,"marketCap":15119141},{"date":"2025-10-31","current":-3.125987,"twenty":-6.274061,"median":-3.505031,"eighty":-1.222938,"marketCap":14089522},{"date":"2025-11-07","current":-3.174079,"twenty":-6.274061,"median":-3.488553,"eighty":-1.222938,"marketCap":14306284},{"date":"2025-11-14","current":-2.8595,"twenty":-6.274061,"median":-3.472619,"eighty":-1.222938,"marketCap":15656445},{"date":"2025-11-21","current":-3.194123,"twenty":-6.274061,"median":-3.441591,"eighty":-1.222938,"marketCap":17488582},{"date":"2025-11-28","current":-3.488185,"twenty":-6.274061,"median":-3.427335,"eighty":-1.222938,"marketCap":19098642},{"date":"2025-12-05","current":-3.143422,"twenty":-6.274061,"median":-3.402659,"eighty":-1.222938,"marketCap":17210986},{"date":"2025-12-12","current":-3.224543,"twenty":-6.274061,"median":-3.37847,"eighty":-1.222938,"marketCap":17655140},{"date":"2025-12-19","current":-4.25883,"twenty":-6.274061,"median":-3.362565,"eighty":-1.222938,"marketCap":23318110},{"date":"2025-12-26","current":-4.715134,"twenty":-6.274061,"median":-3.362565,"eighty":-1.222938,"marketCap":25816479},{"date":"2026-01-02","current":-8.142478,"twenty":-6.276052,"median":-3.362565,"eighty":-1.222938,"marketCap":44582005},{"date":"2026-01-09","current":-7.635474,"twenty":-6.278531,"median":-3.362565,"eighty":-1.222938,"marketCap":41806040},{"date":"2026-01-16","current":-11.417722,"twenty":-6.326095,"median":-3.362565,"eighty":-1.222938,"marketCap":62514743},{"date":"2026-01-23","current":-10.591306,"twenty":-6.326095,"median":-3.362565,"eighty":-1.222938,"marketCap":57989919},{"date":"2026-01-30","current":-9.115925,"twenty":-6.326095,"median":-3.362565,"eighty":-1.222938,"marketCap":49911859},{"date":"2026-02-06","current":-7.828136,"twenty":-6.326095,"median":-3.362565,"eighty":-1.222938,"marketCap":42860907},{"date":"2026-02-13","current":-8.791443,"twenty":-6.326095,"median":-3.362565,"eighty":-1.222938,"marketCap":48135241},{"date":"2026-02-20","current":-9.501248,"twenty":-6.326095,"median":-3.362565,"eighty":-1.222938,"marketCap":52021593},{"date":"2026-02-27","current":-10.140072,"twenty":-6.326095,"median":-3.362565,"eighty":-1.222938,"marketCap":55519310},{"date":"2026-03-06","current":-8.304719,"twenty":-6.363068,"median":-3.362565,"eighty":-1.222938,"marketCap":45470314},{"date":"2026-03-13","current":-6.103604,"twenty":-6.34702,"median":-3.362565,"eighty":-1.222938,"marketCap":58762480},{"date":"2026-03-20","current":-5.542527,"twenty":-6.318344,"median":-3.362565,"eighty":-1.222938,"marketCap":53360711},{"date":"2026-03-27","current":-5.610767,"twenty":-6.278531,"median":-3.362565,"eighty":-1.222938,"marketCap":54017683}],"updateTime":1774711119910},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LPCN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620479730","title":"Lipocine price target raised to $11 from $6.75 at Alliance Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2620479730","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620479730?lang=en_us&edition=fundamental","pubTime":"2026-03-18 00:00","pubTimestamp":1773763259,"startTime":"0","endTime":"0","summary":"Alliance Global raised the firm’s price target on Lipocine (LPCN) to $11 from $6.75 and keeps a Buy rating on the shares. Q4 earnings were within t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lipocine-price-target-raised-to-11-from-6-75-at-alliance-global-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lipocine-price-target-raised-to-11-from-6-75-at-alliance-global-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LPCN"],"gpt_icon":0},{"id":"2618930858","title":"Press Release: Lipocine Announces Financial Results for the Full Year Ended December 31, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2618930858","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618930858?lang=en_us&edition=fundamental","pubTime":"2026-03-10 20:00","pubTimestamp":1773144000,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, March 10, 2026 /PRNewswire/ -- Lipocine Inc. , a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced financial results for the full year ended December 31, 2025 and provided a corporate update.\"We believe 2025 was a pivotal year for Lipocine as we continue to advance our pipeline and expand our market presence. The progress we've made, especially with our postpartum depression therapeutic, LPCN 1154, demonstrates the strength of our science and our team's commitment to delivering more effective treatments for patients in need,\" said Dr Mahesh Patel, Lipocine President and CEO. \"We're excited about the near-term milestones ahead and remain committed to advancing our pipeline proficiently.\". -- Lipocine is developing LPCN 1154, a rapid onset, short treatment duration. oral product candidate comprising the neuroactive steroid brexanolone for. -- The last patient completed the fina","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","LU0061475181.USD","LU1093756325.SGD","LU1093756168.USD","ASM","BK4188","IE0002270589.USD","BK4121","IE00B7SZLL34.SGD","BK4555","BK4081","BK4588","AES","LPCN","03160","GCC","PAM","DRE","IE00B19Z3581.USD","BK4171","BK4105","BK4181","BK4007","PPD","TM","PK","BK4585","BK4519","BK4604","IE00B19Z3B42.SGD","BK4530","BK4561","BK4099","BK4218"],"gpt_icon":0},{"id":"2618493679","title":"Lipocine FY2025 revenue fell 82% to USD 1.98 million as net loss totaled USD 9.6 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2618493679","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618493679?lang=en_us&edition=fundamental","pubTime":"2026-03-10 18:03","pubTimestamp":1773137027,"startTime":"0","endTime":"0","summary":"Lipocine reported a FY 2025 net loss of USD 9.6 million, compared with net income of USD 8,000 a year earlier. FY 2025 revenue fell 82% to USD 1.98 million, driven mainly by USD 1.5 million of license revenue and USD 480,000 of TLANDO royalty revenue versus a prior-year period that included one-time upfront license revenue. Research and development expenses rose 17% to USD 8.58 million, primarily reflecting higher clinical study costs, supplies and research costs, and personnel-related costs. General and administrative expenses fell 25% to USD 3.76 million, mainly due to lower business development, strategic advisory and corporate legal fees tied to prior-year license agreements. Lipocine ended FY 2025 with USD 14.9 million in unrestricted cash, cash equivalents and marketable investment securities, and said it expects existing capital resources to fund projected operating requirements through at least March 31, 2027.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nNDLGtxhD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LPCN"],"gpt_icon":0},{"id":"2618626566","title":"Lipocine Inc  expected to post a loss of 61 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2618626566","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618626566?lang=en_us&edition=fundamental","pubTime":"2026-03-09 20:35","pubTimestamp":1773059704,"startTime":"0","endTime":"0","summary":"Lipocine Inc  expected to post a loss of61cents a share - Earnings Preview Lipocine Inc LPCN.OQ LPCN.O is expected to  show a fall in quarterly revenue when it reports  results on March 11 (estimated)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nL8N3ZX144:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LPCN"],"gpt_icon":0},{"id":"2617564628","title":"Lipocine Files Prospectus to Enable $50M Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2617564628","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617564628?lang=en_us&edition=fundamental","pubTime":"2026-03-05 05:47","pubTimestamp":1772660835,"startTime":"0","endTime":"0","summary":"Lipocine ( ($LPCN) ) has issued an update. On April 26, 2024, Lipocine Inc. entered into a sales agreement with A.G.P./Alliance Global Partners to ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lipocine-files-prospectus-to-enable-50m-stock-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lipocine-files-prospectus-to-enable-50m-stock-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2614507750","title":"BRIEF-Lipocine Files For Common Stock Offering Of Up To $50 Million - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2614507750","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614507750?lang=en_us&edition=fundamental","pubTime":"2026-02-27 06:50","pubTimestamp":1772146243,"startTime":"0","endTime":"0","summary":"BRIEF-Lipocine Files For Common Stock Offering Of Up To $50 Million - SEC FilingFeb 26  - Lipocine Inc LPCN.O:LIPOCINE INC FILES FOR COMMON STOCK OFFERING OF UP TO $50 MILLION - SEC FILINGSource text: [ID:n0001493152-26-008201]Further company coverage: LPCN.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nFWN3ZM27F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LPCN"],"gpt_icon":0},{"id":"2612444551","title":"Lipocine Updates Investor Presentation to Reflect Latest Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2612444551","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612444551?lang=en_us&edition=fundamental","pubTime":"2026-02-18 22:57","pubTimestamp":1771426674,"startTime":"0","endTime":"0","summary":"Lipocine ( ($LPCN) ) has shared an update. Lipocine has updated the corporate presentation it uses in meetings with investors, analysts and other s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lipocine-updates-investor-presentation-to-reflect-latest-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lipocine-updates-investor-presentation-to-reflect-latest-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2612452334","title":"Lipocine Reports Last Patient Last Visit in Phase 3 Trial of LPCN 1154 for Postpartum Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2612452334","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612452334?lang=en_us&edition=fundamental","pubTime":"2026-02-18 21:08","pubTimestamp":1771420133,"startTime":"0","endTime":"0","summary":"Lipocine Inc. reported that the last patient completed the final study visit  in its pivotal Phase 3 randomized, double-blind, placebo-controlled trial of LPCN 1154  for postpartum depression. The study enrolled 90 patients with severe postpartum depression and is evaluating change from baseline in Hamilton depression rating scale  score at Hour 60 as the primary endpoint. Lipocine said safety observations to date included mild-to-moderate nervous system adverse events, with no discontinuations, excessive sedation, loss of consciousness, or drug-related serious adverse events reported. Efficacy results were not presented in the announcement and are expected to be reported in the future.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nNDL6Xp1Jv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LPCN"],"gpt_icon":0},{"id":"2612445650","title":"Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of Lpcn 1154 for Postpartum Depression (Ppd)","url":"https://stock-news.laohu8.com/highlight/detail?id=2612445650","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612445650?lang=en_us&edition=fundamental","pubTime":"2026-02-18 21:00","pubTimestamp":1771419602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nTUA7CCGTN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LPCN"],"gpt_icon":0},{"id":"2605096781","title":"Lipocine Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2605096781","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605096781?lang=en_us&edition=fundamental","pubTime":"2026-01-21 19:41","pubTimestamp":1768995660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LPCN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 21, 2026 06:41 ET (11:41 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LPCN"],"gpt_icon":0},{"id":"2605172106","title":"Lipocine price target raised to $15 from $7 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2605172106","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605172106?lang=en_us&edition=fundamental","pubTime":"2026-01-21 19:15","pubTimestamp":1768994146,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Lipocine (LPCN) to $15 from $7 and keeps a Buy rating on the shares. The firm says LPCN 1154 show...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lipocine-price-target-raised-to-15-from-7-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lipocine-price-target-raised-to-15-from-7-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LPCN"],"gpt_icon":0},{"id":"2604114121","title":"Lipocine Completes Phase 3 Enrollment for Postpartum Depression Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2604114121","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604114121?lang=en_us&edition=fundamental","pubTime":"2026-01-20 22:59","pubTimestamp":1768921148,"startTime":"0","endTime":"0","summary":"Lipocine ( ($LPCN) ) has shared an announcement. On January 20, 2026, Lipocine announced it has completed enrollment and dosing of 90 patients in i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lipocine-completes-phase-3-enrollment-for-postpartum-depression-drug?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lipocine-completes-phase-3-enrollment-for-postpartum-depression-drug?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2604132501","title":"BRIEF-Lipocine Announces Completion Of Enrollment And Dosing In Phase 3 Trial Of LPCN 1154 In Postpartum Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2604132501","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604132501?lang=en_us&edition=fundamental","pubTime":"2026-01-20 21:02","pubTimestamp":1768914147,"startTime":"0","endTime":"0","summary":"BRIEF-Lipocine Announces Completion Of Enrollment And Dosing In Phase 3 Trial Of LPCN 1154 In Postpartum DepressionJan 20 (Reuters) - Lipocine Inc LPCN.O:LIPOCINE ANNOUNCES COMPLETION OF ENROLLMENT AN","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nTUA5NH1ZK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2604113997","title":"Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of Lpcn 1154 in Postpartum Depression (Ppd)","url":"https://stock-news.laohu8.com/highlight/detail?id=2604113997","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604113997?lang=en_us&edition=fundamental","pubTime":"2026-01-20 21:00","pubTimestamp":1768914006,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nTUA5NH1ZK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LPCN"],"gpt_icon":0},{"id":"2604113919","title":"Lipocine Inc - Topline Results Expected Early Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2604113919","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604113919?lang=en_us&edition=fundamental","pubTime":"2026-01-20 21:00","pubTimestamp":1768914006,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nTUA5NH1ZK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2603529135","title":"Lipocine updates investor presentation and corporate materials","url":"https://stock-news.laohu8.com/highlight/detail?id=2603529135","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603529135?lang=en_us&edition=fundamental","pubTime":"2026-01-13 05:48","pubTimestamp":1768254510,"startTime":"0","endTime":"0","summary":"Lipocine ( ($LPCN) ) has shared an announcement. Lipocine reported that it has updated the corporate presentation it uses in discussions with inves...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lipocine-updates-investor-presentation-and-corporate-materials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lipocine-updates-investor-presentation-and-corporate-materials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4544","BK4007","LPCN","BK4588","BK4585","ARKG"],"gpt_icon":0},{"id":"2602541332","title":"Lipocine Advances Phase 3 Postpartum Depression Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2602541332","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602541332?lang=en_us&edition=fundamental","pubTime":"2026-01-12 23:01","pubTimestamp":1768230116,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Lipocine ( ($LPCN) ). On January 12, 2026, Lipocine reported that an independent Data Safety Monitoring Board c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lipocine-advances-phase-3-postpartum-depression-drug-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lipocine-advances-phase-3-postpartum-depression-drug-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LPCN"],"gpt_icon":0},{"id":"2602951079","title":"Lipocine: DSMB recommended Phase 3 LPCN 1154 continue as planned","url":"https://stock-news.laohu8.com/highlight/detail?id=2602951079","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602951079?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:16","pubTimestamp":1768223784,"startTime":"0","endTime":"0","summary":"Lipocine (LPCN) announced the completion of a scheduled independent Data Safety Monitoring Board review of its ongoing Phase 3 clinical trial evalu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lipocine-dsmb-recommended-phase-3-lpcn-1154-continue-as-planned-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lipocine-dsmb-recommended-phase-3-lpcn-1154-continue-as-planned-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LPCN","BK4007"],"gpt_icon":0},{"id":"2602569510","title":"Lipocine Completes Phase 3 Safety Review of LPCN 1154 for Postpartum Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2602569510","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602569510?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:03","pubTimestamp":1768223022,"startTime":"0","endTime":"0","summary":"Lipocine Inc. has announced the completion of the second scheduled independent Data Safety Monitoring Board  review for its ongoing Phase 3 clinical trial evaluating LPCN 1154, an oral formulation of brexanolone, for the rapid relief treatment of postpartum depression . The DSMB assessed all available safety data from 82 randomized participants, with 74 having completed dosing, and recommended the trial continue as planned without modification. No drug discontinuations, excessive sedation, loss of consciousness, or drug-related serious adverse events have been reported. The company is no longer screening new participants but continues to enroll those who have already met eligibility criteria. Lipocine expects to report topline safety and efficacy results from the study early in the second quarter of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL8QvdcB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LPCN"],"gpt_icon":0},{"id":"2602774517","title":"Lipocine Reports Encouraging Progress Post Second Interim Safety Review in Phase 3 Trial of Lpcn 1154 in Postpartum Depression (Ppd)","url":"https://stock-news.laohu8.com/highlight/detail?id=2602774517","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602774517?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:00","pubTimestamp":1768222802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA3HBTSX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LPCN","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":47,"code":"91000000","status":"200"}]}}